Heska Corporation (HSKA) EPS Estimated At $0.40

April 17, 2018 - By Robert Sims

Investors sentiment decreased to 0.77 in Q4 2017. Its down 0.49, from 1.26 in 2017Q3. It turned negative, as 20 investors sold Heska Corporation shares while 51 reduced holdings. 21 funds opened positions while 34 raised stakes. 5.99 million shares or 8.21% more from 5.53 million shares in 2017Q3 were reported.
Secor Cap L P accumulated 7,047 shares. Invesco Limited reported 18,993 shares stake. Albion Fincl Grp Incorporated Ut holds 6,291 shares or 0.08% of its portfolio. State Street holds 185,215 shares or 0% of its portfolio. Moreover, Redmile Limited Company has 0.69% invested in Heska Corporation (NASDAQ:HSKA). Barclays Public Limited Company invested in 1,894 shares or 0% of the stock. Ny State Common Retirement Fund holds 0% in Heska Corporation (NASDAQ:HSKA) or 7,200 shares. D E Shaw And Co reported 5,877 shares. Gabelli Funds Limited Com holds 0% or 4,000 shares in its portfolio. Great West Life Assurance Co Can invested 0% in Heska Corporation (NASDAQ:HSKA). Victory Capital Mgmt holds 0% or 1,376 shares in its portfolio. Riverbridge Prns Ltd owns 198,806 shares. Thrivent Fincl For Lutherans, Minnesota-based fund reported 93,910 shares. 4,600 were reported by Tokio Marine Asset Management Limited. Teton holds 0.08% or 11,000 shares in its portfolio.

Analysts expect Heska Corporation (NASDAQ:HSKA) to report $0.40 EPS on May, 1.They anticipate $0.21 EPS change or 34.43 % from last quarter’s $0.61 EPS. HSKA’s profit would be $2.97 million giving it 49.33 P/E if the $0.40 EPS is correct. After having $0.63 EPS previously, Heska Corporation’s analysts see -36.51 % EPS growth. The stock increased 1.21% or $0.94 during the last trading session, reaching $78.92. About 60,555 shares traded. Heska Corporation (NASDAQ:HSKA) has declined 19.59% since April 17, 2017 and is downtrending. It has underperformed by 31.14% the S&P500.

Heska Corporation (NASDAQ:HSKA) Ratings Coverage

Among 3 analysts covering Heska Corp (NASDAQ:HSKA), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Heska Corp had 4 analyst reports since October 27, 2017 according to SRatingsIntel. The rating was maintained by B. Riley & Co on Thursday, March 1 with “Neutral”.

Heska Corporation develops, manufactures, and markets advanced veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company has market cap of $586.18 million. It operates through two divisions, Core Companion Animal Health; and Other Vaccines, Pharmaceuticals and Products. It has a 60.71 P/E ratio. The Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure white and red blood cell count, platelet count, and hemoglobin levels in animals; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and IV pumps.

Heska Corporation (NASDAQ:HSKA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.